New Materials market report from GBI Research: "Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity"

Boston, MA -- (SBWire) -- 07/28/2012 --GBI Research's report, "Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity" provides detailed insight into the Europe API market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the API markets in this region. The report contains market forecasts, product type analysis, drivers and restraints. In addition, it includes market forecasts, product type analysis, therapeutic categories analysis and CMO growth in the region and its influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the Europe API market, covering all the major parameters.

View Full Report Details and Table of Contents

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Europe is the third largest regional market for APIs by revenue in the world. European active pharmaceutical ingredients (API) market revenue held a share of around 24.2% of global API market revenue of 108.6 $ billion in 2011. Total revenue generated by the European API market was $26,288.96 million in 2011 and is expected to grow at a CAGR of 6.5% to reach $38,255.67 million by 2017.This will be supported by healthy demand from generic and biotech API sectors.

Scope

- Market revenue data for APIs from 2005 to 2011 and forecast for six years to 2017.
- API markets in key countries in the region: Germany, France, Italy, the Uk, Spain
- API industry structure and market trends such as a shift in manufacturing and growth in biotechnology for the Europe region.
- Drivers of the API market, such as the growth of generic drugs, and restraints, such as patent expiries and government initiatives like price reimbursement cut.
- Detailed historical, forecast trend and share analysis of API revenue based on product types (Synthetic and Biotech APIs) in the Europe market and in key countries of the region.
- Detailed historical, forecast trend and share analysis of API revenue based on customer base (Generic and Innovative for Synthetic APIs) (Biosimilars and biologics for Biotech Apis) in the Europe market and in key countries of the region.
- Analysis of API revenue based on therapeutic categories in the Europe and key countries.

Reasons to Get this Report

- Develop business strategies with the help of specific insights on the Europe API market.
- Identify opportunities and challenges in the Europe API market.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Materials research reports at Fast Market Research

You may also be interested in these related reports:

- Active Pharmaceutical Ingredients (APIs) in the Americas Market to 2016 - Growth in Biotechnology and Generic Segments and the Pharmaceutical Patent Cliff will Shape the Landscape
- Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases
- Pharmaceutical Pricing and Reimbursement in Europe - Reference Pricing and Similar Initiatives Being Applied to Innovative Drugs Pose Significant Challenge to Pharmaceutical Companies
- Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs
- Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs
- The Pharmaceutical Market: France
- The World Generic Market Report 2012
- The Pharmaceutical Market: Italy
- Emerging Pharmaceutical Market in South Africa to 2017 - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
- Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry